110 related articles for article (PubMed ID: 31255446)
1. Autoantibody-targeted TAAs in pancreatic cancer: A comprehensive analysis.
Zhou Y; Cui J; Du H
Pancreatology; 2019 Jul; 19(5):760-768. PubMed ID: 31255446
[TBL] [Abstract][Full Text] [Related]
2. Serum autoantibodies to pancreatic cancer antigens as biomarkers of pancreatic cancer in a San Francisco Bay Area case-control study.
Bracci PM; Zhou M; Young S; Wiemels J
Cancer; 2012 Nov; 118(21):5384-94. PubMed ID: 22517435
[TBL] [Abstract][Full Text] [Related]
3. Immunodiagnostic value of combined detection of autoantibodies to tumor-associated antigens as biomarkers in pancreatic cancer.
Li J; Wang LJ; Ying X; Han SX; Bai E; Zhang Y; Zhu Q
Scand J Immunol; 2012 Mar; 75(3):342-9. PubMed ID: 22010875
[TBL] [Abstract][Full Text] [Related]
4. A systematic review of serum autoantibodies as biomarkers for pancreatic cancer detection.
Dumstrei K; Chen H; Brenner H
Oncotarget; 2016 Mar; 7(10):11151-64. PubMed ID: 26840568
[TBL] [Abstract][Full Text] [Related]
5. Mini-array of multiple tumor-associated antigens (TAAs) in the immunodiagnosis of esophageal cancer.
Qin JJ; Wang XR; Wang P; Ren PF; Shi JX; Zhang HF; Xia JF; Wang KJ; Song CH; Dai LP; Zhang JY
Asian Pac J Cancer Prev; 2014; 15(6):2635-40. PubMed ID: 24761876
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
[TBL] [Abstract][Full Text] [Related]
7. Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis.
Zhu Q; Liu M; Dai L; Ying X; Ye H; Zhou Y; Han S; Zhang JY
Autoimmun Rev; 2013 Oct; 12(12):1123-8. PubMed ID: 23806562
[TBL] [Abstract][Full Text] [Related]
8. Survey of autoantibody responses against tumor-associated antigens in thyroid cancer.
Abols A; Ducena K; Zayakin P; Silina K; Kalnina Z; Sadovska L; Tars J; Vilmanis J; Narbuts Z; Eglitis J; Pirags V; Line A
Cancer Biomark; 2014; 14(5):361-9. PubMed ID: 25171478
[TBL] [Abstract][Full Text] [Related]
9. Composition and production of pancreatic tumor related antigens.
Appert HE
Int J Pancreatol; 1990; 7(1-3):13-24. PubMed ID: 2081918
[TBL] [Abstract][Full Text] [Related]
10. Profiling of autoantibodies in sera of pancreatic cancer patients.
Nagayoshi Y; Nakamura M; Matsuoka K; Ohtsuka T; Mori Y; Kono H; Aso T; Ideno N; Takahata S; Ryo A; Takeda H; Ito T; Oda Y; Endo Y; Sawasaki T; Tanaka M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S459-65. PubMed ID: 24585405
[TBL] [Abstract][Full Text] [Related]
11. Serological proteome analysis approach-based identification of ENO1 as a tumor-associated antigen and its autoantibody could enhance the sensitivity of CEA and CYFRA 21-1 in the detection of non-small cell lung cancer.
Dai L; Qu Y; Li J; Wang X; Wang K; Wang P; Jiang BH; Zhang J
Oncotarget; 2017 May; 8(22):36664-36673. PubMed ID: 28456790
[TBL] [Abstract][Full Text] [Related]
12. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with breast cancer.
Liu Y; Liao Y; Xiang L; Jiang K; Li S; Huangfu M; Sun S
Int J Clin Oncol; 2017 Apr; 22(2):291-296. PubMed ID: 27778118
[TBL] [Abstract][Full Text] [Related]
13. A panel of autoantibodies as potential early diagnostic serum biomarkers in patients with cervical cancer.
Huangfu M; Xu S; Li S; Sun B; Lee KH; Liu L; Sun S
Tumour Biol; 2016 Jul; 37(7):8709-14. PubMed ID: 26738866
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of a new tumor marker, Span-1, for the diagnosis of pancreatic cancer.
Kiriyama S; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Ono H; Sakai Y
Cancer; 1990 Apr; 65(7):1557-61. PubMed ID: 2311067
[TBL] [Abstract][Full Text] [Related]
15. Tumor associated antigens or anti-TAA autoantibodies as biomarkers in the diagnosis of ovarian cancer: a systematic review with meta-analysis.
Shi JX; Qin JJ; Ye H; Wang P; Wang KJ; Zhang JY
Expert Rev Mol Diagn; 2015 Jun; 15(6):829-52. PubMed ID: 25959246
[TBL] [Abstract][Full Text] [Related]
16. An autoantibody-mediated immune response to calreticulin isoforms in pancreatic cancer.
Hong SH; Misek DE; Wang H; Puravs E; Giordano TJ; Greenson JK; Brenner DE; Simeone DM; Logsdon CD; Hanash SM
Cancer Res; 2004 Aug; 64(15):5504-10. PubMed ID: 15289361
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Associated Antigens (TAAs) for the Serological Diagnosis of Osteosarcoma.
Li J; Qin B; Huang M; Ma Y; Li D; Li W; Guo Z
Front Immunol; 2021; 12():665106. PubMed ID: 33995397
[TBL] [Abstract][Full Text] [Related]
18. Protein arrays as tools for serum autoantibody marker discovery in cancer.
Kijanka G; Murphy D
J Proteomics; 2009 Aug; 72(6):936-44. PubMed ID: 19258055
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors.
Osako M; Yonezawa S; Siddiki B; Huang J; Ho JJ; Kim YS; Sato E
Cancer; 1993 Apr; 71(7):2191-9. PubMed ID: 8384065
[TBL] [Abstract][Full Text] [Related]
20. Detection of autoantibodies to a panel of tumor-associated antigens for the diagnosis values of gastric cardia adenocarcinoma.
Zhou SL; Ku JW; Fan ZM; Yue WB; Du F; Zhou YF; Liu YL; Li Y; Tang S; Hu YL; Hu XP; Hou ZC; Liu J; Liu Y; Feng XS; Wang LD
Dis Esophagus; 2015; 28(4):371-9. PubMed ID: 24612004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
